216 related articles for article (PubMed ID: 9029482)
1. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
[TBL] [Abstract][Full Text] [Related]
2. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
[TBL] [Abstract][Full Text] [Related]
3. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
4. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
5. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
6. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
[TBL] [Abstract][Full Text] [Related]
7. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone.
Graham A; Wakamatsu K; Hunt G; Ito S; Thody AJ
Pigment Cell Res; 1997 Oct; 10(5):298-303. PubMed ID: 9359625
[TBL] [Abstract][Full Text] [Related]
8. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone.
Solca FF; Chluba-de Tapia J; Iwata K; Eberle AN
FEBS Lett; 1993 May; 322(2):177-80. PubMed ID: 8482388
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of the human MSH receptor in a mouse melanoma cell line.
Chluba-de Tapia J; Bagutti C; Wikberg JS; Chhajlani V; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):43-53. PubMed ID: 8903930
[TBL] [Abstract][Full Text] [Related]
10. Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis.
Hunt G; Thody AJ
J Endocrinol; 1995 Nov; 147(2):R1-4. PubMed ID: 7490543
[TBL] [Abstract][Full Text] [Related]
11. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
12. The melanocortin-1 receptor and human pigmentation.
Abdel-Malek Z; Suzuki I; Tada A; Im S; Akcali C
Ann N Y Acad Sci; 1999 Oct; 885():117-33. PubMed ID: 10816645
[TBL] [Abstract][Full Text] [Related]
13. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
14. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
15. A selective protein kinase C inhibitor (CGP 41251) positively and negatively modulates melanoma cell MSH receptors.
Siegrist W; Sauter P; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):283-96. PubMed ID: 8903945
[TBL] [Abstract][Full Text] [Related]
16. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
17. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines.
Siegrist W; Stutz S; Eberle AN
Cancer Res; 1994 May; 54(10):2604-10. PubMed ID: 8168086
[TBL] [Abstract][Full Text] [Related]
18. [MC1R--the key gene in mammalian melanin synthesis].
Yang YS; Li N; Deng XM; Wu CX
Yi Chuan; 2004 Jul; 26(4):544-50. PubMed ID: 15640059
[TBL] [Abstract][Full Text] [Related]
19. trans-Caffeic acid stearyl ester from Paeonia suffruticosa inhibits melanin synthesis by cAMP-mediating down-regulation of α-melanocyte-stimulating hormone-stimulated melanogenesis signaling pathway in B16 cells.
Liang CH; Chou TH; Tseng YP; Ding HY
Biol Pharm Bull; 2012; 35(12):2198-203. PubMed ID: 23207771
[TBL] [Abstract][Full Text] [Related]
20. Homologous regulation of the MSH receptor in melanoma cells.
Siegrist W; Eberle AN
J Recept Res; 1993; 13(1-4):263-81. PubMed ID: 8383755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]